Intravesical therapy for bladder cancer

Author： Williams Steve K   Hoenig David M   Ghavamian Reza   Soloway Mark  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.6, 2010-04, pp. : 947-958

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical Therapy of Superficial Bladder Cancer

By  

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 345-359

Bentham Science Publishers

Access to resources Recommend Favorite

Intravesical valrubicin for bladder cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 268, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

Epirubicin: A Review of its Intravesical Use in Superficial Bladder Cancer

By Onrust S.V.   Wiseman L.R.   Goa K.L.  

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 307-333

Adis International

Access to resources Recommend Favorite

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

By Yutkin Vladimir   Chin Joseph  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 251-260

Informa Healthcare

Access to resources Recommend Favorite